Comment
. 2003 Oct 18;362(9392):1328; author reply 1330-1.
doi: 10.1016/S0140-6736(03)14590-4.
Breast cancer and hormone-replacement therapy: the Million Women Study
- PMID: 14575985
- DOI: 10.1016/S0140-6736(03)14590-4
Item in Clipboard
Comment
Breast cancer and hormone-replacement therapy: the Million Women Study
Lancet.
.
No abstract available
Comment on
-
Breast cancer and hormone-replacement therapy in the Million Women Study.Lancet. 2003 Aug 9;362(9382):419-27. doi: 10.1016/s0140-6736(03)14065-2. Lancet. 2003. PMID: 12927427
Similar articles
-
Breast cancer and hormone-replacement therapy: the Million Women Study.Lancet. 2003 Oct 18;362(9392):1329; author reply 1330-1. doi: 10.1016/s0140-6736(03)14592-8. Lancet. 2003. PMID: 14575987 No abstract available.
-
Breast cancer and hormone-replacement therapy: the Million Women Study.Lancet. 2003 Oct 18;362(9392):1330; author reply 1330-1. doi: 10.1016/S0140-6736(03)14593-X. Lancet. 2003. PMID: 14575988 No abstract available.
-
Postmenopausal hormone therapy and breast cancer.Prescrire Int. 2009 Apr;18(100):66-7. Prescrire Int. 2009. PMID: 19585723
-
[Hormone replacement therapy in menopause and risk of breast cancer].Presse Med. 2000 Oct 21;29(31):1688-93. Presse Med. 2000. PMID: 11094609 Review. French.
-
Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.J Clin Endocrinol Metab. 2001 Jan;86(1):16-23. doi: 10.1210/jcem.86.1.7269. J Clin Endocrinol Metab. 2001. PMID: 11231971 Review. No abstract available.
Cited by
-
Cardiomyocyte-targeted and 17β-estradiol-loaded acoustic nanoprobes as a theranostic platform for cardiac hypertrophy.J Nanobiotechnology. 2018 Mar 30;16(1):36. doi: 10.1186/s12951-018-0360-3. J Nanobiotechnology. 2018. PMID: 29602311 Free PMC article.
-
The million women study: a critique.Endocrine. 2004 Aug;24(3):187-93. doi: 10.1385/ENDO:24:3:187. Endocrine. 2004. PMID: 15542884
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
